Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT04148534 |
Other study ID # |
D-4-2019 |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
November 1, 2019 |
Est. completion date |
November 15, 2020 |
Study information
Verified date |
June 2022 |
Source |
Cairo University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
compare the operating condition of two different levels of muscle relaxation on facial nerve
monitoring using transcranial motor evocked potential in CPA surgery .
- To Estimate End to start facial nerve MEP amplitude ratio
- To determine the effect of neuromuscular relaxant degrees on recovery and
- Assessment of propofol doses needed for enhancement of early recovery and ambulation.
Description:
40 Patients aged from 18-60 years old undergoing Cerebellopontine angle surgery. Patients
will be one of two groups: Both Induction will be accomplished with fentanyl, propofol ,
rocronium infusion will be given randomly to one of the groups.
Depth of anaesthesia, neurotransmitter monitoring and facial nerve neurophysiological
monitoring will be done.